Tenecteplase for Intravenous Stroke Thrombolysis in Recent DOAC Users

Summary

An investigator-initiated, multicenter, randomized, placebo-controlled, double-blind trial to determine the efficacy and safety of intravenous tenecteplase thrombolysis in acute ischemic stroke (AIS) patients with recent direct oral anticoagulants (DOACs) intake in improving the 90-day functional outcome.

Timeline

Start

2025-08-14

Primary completion

2028-09-01

Completion

2028-12-31

Drugs

Indications